As a key folate‐dependent enzyme in the de novo purine synthesis pathway, GART facilitates nucleotide production essential for DNA replication [21] and is frequently overexpressed in aggressive malignancies, including hepatocellular carcinoma [22], glioma [23], and colorectal cancer [24]. Here, GART is linked to hepatocellular carcinoma.